Find comprehensive information on Multinodular Thyroid including clinical documentation, medical coding, ICD-10 codes, diagnosis codes, differential diagnosis, thyroid nodules, ultrasound findings, goiter, and hyperthyroidism. Learn about the diagnosis, treatment, and management of Multinodular Thyroid from reputable healthcare resources for accurate medical coding and clinical documentation practices. This resource provides essential information for healthcare professionals, medical coders, and billers seeking clarification on Multinodular Thyroid.
Also known as
Nontoxic multinodular goiter
Enlarged thyroid with multiple nodules, not producing excess hormones.
Other specified nontoxic goiter
Nontoxic goiter not classified elsewhere, potentially including multinodular variants.
Unspecified nontoxic goiter
Nontoxic goiter without further specification, possibly multinodular.
When to use each related code
| Description |
|---|
| Multinodular Goiter |
| Thyroid Cyst |
| Toxic Multinodular Goiter |
Q: How can I differentiate between benign multinodular goiter and suspicious thyroid nodules requiring further workup in patients with a multinodular thyroid?
A: Differentiating benign multinodular goiter from suspicious thyroid nodules requires a thorough evaluation incorporating patient history, physical examination, and appropriate imaging studies. While the majority of multinodular goiters are benign, certain features warrant further investigation. Specifically, consider features such as rapid nodule growth, presence of microcalcifications, hypoechogenicity on ultrasound, irregular margins, taller-than-wide shape, and cervical lymphadenopathy as suspicious. Serum TSH and thyroglobulin levels can also contribute to risk stratification. Fine-needle aspiration biopsy (FNAB) is the gold standard for evaluating suspicious nodules identified on ultrasound. Explore how our risk stratification tools can aid in identifying high-risk patients and consider implementing a standardized protocol for managing patients with multinodular thyroid disease. This protocol should encompass guidelines for initial evaluation, ultrasound criteria for FNAB, and follow-up recommendations.
Q: What are the best practices for ultrasound surveillance of a multinodular thyroid, including recommended frequency and criteria for intervention based on ATA guidelines?
A: Ultrasound surveillance of multinodular thyroid should be guided by the American Thyroid Association (ATA) guidelines and tailored to individual patient risk factors. For patients with predominantly benign-appearing nodules and no concerning features, repeat ultrasound may not be necessary unless new symptoms arise. However, if any suspicious features are present, such as those mentioned previously (rapid growth, microcalcifications, etc.), more frequent monitoring is indicated. The ATA guidelines recommend considering FNAB for nodules greater than 1 cm with suspicious sonographic features, while smaller nodules with high-risk sonographic patterns also warrant evaluation. Learn more about the specific ATA recommendations for ultrasound surveillance intervals and criteria for intervention, which depend on the individual nodule characteristics and patient risk profile. Consider implementing these evidence-based guidelines to ensure appropriate management of patients with multinodular thyroid.
Patient presents with complaints possibly indicative of multinodular goiter, including palpable thyroid nodules, potential thyroid enlargement, and occasional symptoms such as dysphagia or dyspnea, though asymptomatic presentation is also common. Physical examination reveals a palpable, irregular thyroid gland with multiple distinct nodules. No cervical lymphadenopathy was appreciated. Thyroid function tests, including TSH, free T4, and free T3, were ordered to assess thyroid hormone levels and evaluate for hyperthyroidism or hypothyroidism. Thyroid ultrasound was performed, confirming the presence of multiple thyroid nodules and providing detailed characteristics regarding nodule size, composition, and vascularity, essential for risk stratification. Fine-needle aspiration biopsy (FNAB) is recommended for nodules meeting specific size and sonographic criteria to rule out thyroid cancer. Differential diagnosis includes simple goiter, Hashimoto's thyroiditis, Graves' disease, and thyroid neoplasms. Patient education was provided regarding the nature of multinodular thyroid disease, the importance of surveillance, and potential treatment options, including radioactive iodine therapy, thyroid hormone suppression therapy, or surgery (thyroidectomy) depending on the results of FNAB and the patient's clinical picture. Follow-up appointment scheduled to review lab results, discuss FNAB findings if performed, and formulate a definitive management plan. ICD-10 code E04.2 (Nontoxic multinodular goiter) is considered pending further evaluation. Medical decision making based on current clinical presentation, laboratory results, and imaging findings.